Neuberger Berman Group’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-103,709
| Closed | -$34.7K | – | 1944 |
|
|
2024
Q2 | $34.7K | Sell |
103,709
-645,112
| -86% | -$216K | ﹤0.01% | 1851 |
|
|
2024
Q1 | $869K | Sell |
748,821
-1,022,615
| -58% | -$1.19M | ﹤0.01% | 1324 |
|
|
2023
Q4 | $2.99M | Sell |
1,771,436
-358,409
| -17% | -$606K | ﹤0.01% | 1028 |
|
|
2023
Q3 | $3.86M | Buy |
2,129,845
+8,479
| +0.4% | +$15.3K | ﹤0.01% | 940 |
|
|
2023
Q2 | $3.95M | Sell |
2,121,366
-155,689
| -7% | -$290K | ﹤0.01% | 941 |
|
|
2023
Q1 | $3.03M | Sell |
2,277,055
-44,394
| -2% | -$59K | ﹤0.01% | 984 |
|
|
2022
Q4 | $3.92M | Buy |
2,321,449
+564,028
| +32% | +$953K | ﹤0.01% | 914 |
|
|
2022
Q3 | $5.48M | Buy |
1,757,421
+47,633
| +3% | +$149K | 0.01% | 864 |
|
|
2022
Q2 | $4.07M | Sell |
1,709,788
-327,598
| -16% | -$780K | ﹤0.01% | 947 |
|
|
2022
Q1 | $8.21M | Buy |
2,037,386
+101,280
| +5% | +$408K | 0.01% | 845 |
|
|
2021
Q4 | $16.1M | Sell |
1,936,106
-681,720
| -26% | -$5.67M | 0.01% | 740 |
|
|
2021
Q3 | $30.3M | Buy |
+2,617,826
| New | +$30.3M | 0.03% | 581 |
|